Articles tagged with Spinal Cord
The partnership aims to translate early research into new treatments for chronic spinal cord injuries, which currently leave patients with lifelong suffering. Dr. Evan Snyder and Dr. Mark Tuszynski will lead the effort to use stem cells to repair damaged neural cells in adults.
Scientists have determined that pain and itch are regulated by different molecular mechanisms. Researchers at WashU Medicine separated itch and pain sensations in mice, a finding that could have important implications for treating both pain and chronic itching. GRPR gene plays key role in transmitting itching sensations.
Researchers found that direct implantation of mesenchymal stem cells did not remyelinate the damaged area, but still consider MSCs a promising tool for neurological disorders due to their pre-clinical efficacy in treating stroke and MS.
Interferon-gamma plays a deciding role in whether immune cells attack and injure the central nervous system in mice. The protein is protective in cerebellums and brainstems but causes nerve cell damage in spinal cords.
A team of chemists at Johns Hopkins University has developed water-soluble electronic materials that spontaneously assemble into 'wires' with potential for biomedical applications. The researchers are exploring the use of these materials to guide electrical current and regulate cell-to-cell communication.
In a breakthrough for ALS research, scientists successfully transplanted stem cell-like cells into rat models of the disease, slowing neuron loss and extending life. The treatment targets the cervical spinal cord, where motor neurons are most vulnerable to damage.
A new study in mice with an MS-like disease found that the brain's response to a specific immune protein, interferon-g (IFNg), dictates which part of the brain is attacked. This discovery may bring scientists closer to understanding the variable manifestations of human multiple sclerosis.
V3 neurons play a vital role in maintaining balance between both sides of the body, ensuring robust stepping rhythms. The discovery provides an important milestone in understanding neural circuitry that coordinates walking movements.
Researchers at Northwestern University believe spicy food, including pepperoni pizza, can worsen pelvic pain and urinary frequency in women with interstitial cystitis. A new treatment approach using anesthetic patches or suppositories may provide relief.
Purdue University researchers have developed a method of using nanoparticles to deliver treatments to injured brain and spinal cord cells. The team coated silica nanoparticles with a polymer to target and repair injured guinea pig spinal cords, showing improved physiological functioning in treated cells.
Researchers found that pain signals from arthritic joints worsen and expand the disease by transferring inflammation to the spinal cord. New treatments aim to interrupt 'crosstalk' between joints and the spinal cord to treat osteoarthritis.
Researchers identified a new immune polyradiculoneuropathy affecting workers at several pork processing plants, causing nerve damage and inflammation in legs. Thirteen out of 15 patients showed elevated protein levels in cerebrospinal fluid and activation of their immune systems.
Research finds that leaky blood vessels in mice with ALS mutations expose neurons to toxic substances, contributing to disease progression. The study opens a new front in understanding ALS, a debilitating disease that affects motor neurons.
Researchers at Northwestern University have developed a nano-engineered gel that inhibits scar tissue formation and enables spinal cord fiber regeneration. This breakthrough allows mice with spinal cord injuries to walk again after six weeks, paving the way for potential human trials.
Dr. Richard Stein has been awarded the Barbara Turnbull Award for Spinal Cord Research, a $50,000 prize, for his work on direct, microelectrical spinal cord stimulation. His innovative device aims to record sensory feedback from muscles and nerves in legs and hips to help paralyzed individuals walk.
Researchers from the Trainor Lab have characterized a crucial gene that regulates neural cell differentiation and proliferation during embryonic development. The study reveals how this gene, Cux2, integrates cell cycle progression with neural progenitor differentiation to shape the spinal cord.
A new study suggests that taking folic acid supplements for at least one year before pregnancy can significantly reduce the risk of premature birth. The research found a 50-70% decrease in early preterm deliveries, with the greatest reduction seen in very early premature births.
Researchers discovered that the central nervous system can reorganize itself and follow new pathways to restore cellular communication required for movement. The study, published in Nature Medicine, shows that most mice regained mobility within eight weeks after spinal cord damage was induced.
Researchers at the Salk Institute have identified a key signal guiding motor neuron navigation, Magellan, which helps them reach their target destinations. The mutation affects the structure of growing neurons, causing them to lose direction and form abnormal 'kinks' or coils.
A study published in PLOS ONE found that mice with amyotrophic lateral sclerosis (ALS) have a compromised blood-spinal cord barrier, leading to vascular leakage and potential mechanisms for motor neuron damage. Researchers hope this finding will lead to the development of new treatments targeting the barrier's repair.
Scientists at UCSD School of Medicine identified a potential new therapy for chronic spasticity and rigidity, a painful condition often resulting from spinal cord injuries. They found that the AMPA receptor antagonist NGX424 suppresses spasticity and rigidity in rats, providing a novel means of reducing muscle tone.
A team of scientists at the University of Wisconsin-Madison has shown that stem cells engineered to secrete a key growth factor can protect motor neurons characteristic of amyotrophic lateral sclerosis (ALS), but not restore muscle connections. The study demonstrates promise for cell-based therapies in diseases with few treatment options.
Researchers discovered the GRPR gene, which codes for a receptor involved in transmitting itch signals from the skin to the brain. Laboratory mice lacking this gene scratched less when exposed to itchy stimuli, suggesting a potential target for anti-itch medication.
Researchers found that combining radiation therapy and microsurgery can significantly increase the body's ability to repair damaged spinal cords, leading to permanent recovery. The treatment, which involves draining excess fluids and eliminating damaging cells, showed a nearly two-fold improvement in wound healing compared to untreated...
Researchers at UC San Diego report that grafting human spinal stem cells into paralyzed rats restored ambulatory function within six weeks. The study demonstrates the potential of stem cell therapy to reconstruct neural circuitry and treat debilitating muscle spasticity.
Xuejun Wen aims to repair spinal cord nerves using tissue engineering and implantable bridging devices. His research has the potential to improve lives and generate commercial interest.
Research reveals how interneurones process information from senses and brain to control movement, with persistent sodium current playing a critical role. Abnormal regulation of this current may impair motor command integration, affecting normal movement patterns.
A group of European researchers developed a spinal cord model and implemented it in an amphibious salamander-like robot. The robot changes its speed and gait in response to simple electrical signals, suggesting that the distributed neural system in the spinal cord holds the key to vertebrates' complex locomotor capabilities.
Researchers mapped neurons in zebrafish spinal cords to understand how they control movement speed, revealing a surprising pattern that regulates slow and fast movements. The study opens a door to basic understanding of spinal cord architecture and function.
A 'smart bladder pacemaker' developed by Duke University researchers selectively coordinates the contraction and release of muscles required for maintaining continence. The device taps into the urinary circuit in the spinal cord, effectively emptying the bladder and increasing bladder capacity.
Researchers have successfully transplanted human nerve stem cells into rats' damaged spinal cords, which survived, grew, and formed connections with native cells. The breakthrough establishes a new doctrine for regenerative neuroscience, suggesting the spinal cord can support transplanted cell development.
Researchers successfully differentiated human neural stem cell grafts into functional neurons in the spinal cord of adult rats, growing axons and forming synapses with motor neurons. However, further studies are needed to determine whether these cells can function correctly and provide benefits for patients.
Researchers investigated opioid analgesic abuse and found it is more prevalent in rural areas, with teenagers increasingly affected. Spinal cord stimulation also showed significant results in managing axial low back pain associated with failed back surgery syndrome.
Researchers at the University of Texas Medical Branch discovered a potential method to prevent failed back surgery syndrome (FBSS) by applying a local anesthetic, Lidocaine, to the exposed spinal cord before surgery. The technique successfully blocked the release of chemicals associated with FBSS and reduced sensitivity in rats.
Researchers have discovered that spinal cord neurons show irregular firing patterns during network activity, similar to the cerebral cortex. This finding enables exploration of how spinal cords generate movements, shedding light on the complex system controlling human motion.
Researchers at Barrow and Arizona State University will develop new hydrogels to stimulate spinal cord growth and treat brain tumors. The studies aim to improve treatment options for patients with malignant brain tumors and spinal cord injuries, building on the center's reputation as a top neuroscience hub.
Dr. Pierre Drapeau's research on zebrafish embryos has led to the discovery of signaling between nerve cells' importance in spinal cord development and growth. The $50,000 Barbara Turnbull Award supports his work towards understanding spinal cord repair and potentially treating diseases such as schizophrenia and autism.
Dr. Pierre Drapeau is being awarded the highest distinction in Canadian spinal cord research for his pioneering study of spinal cord development using the zebrafish embryo. This groundbreaking work has opened new avenues for understanding vertebrate development and genetics.
Researchers at Oregon State University developed a new method to identify DNA-binding transcription factors that help steer stem cells. The study, announced in Proceedings of the National Academy of Sciences, used mouse embryonic spinal cord as a model and identified the subset of genes involved in producing various cell types.
A key gene, Boc, has been identified as crucial for brain neural circuit formation and axon guidance in the nervous system. This discovery could lead to novel strategies for treating neurodegenerative diseases such as Alzheimer's and Parkinson's, and spinal cord injuries.
Researchers at Case Western Reserve University developed a method to bypass spinal cord injuries by regenerating severed nerve fibers and reconnecting them with the spinal cord. The treatment, using an enzyme called chondroitinase, resulted in improved mobility in rats with impaired motor functions.
Researchers at Johns Hopkins and the University of Michigan have developed a treatment that helps spinal cord nerves regrow after injury. Using an enzyme called sialidase, they increased the number of new nerve fibers in injured rats by more than twice, compared to untreated controls.
Researchers found that diazoxide prevented hind limb paralysis in rabbits, improving mobility despite impaired hopping. Mitochondrial damage was significantly reduced with diazoxide treatment, reducing reactive oxygen species and oxidative DNA damage.
A study by Martyn Goulding and colleagues reveals that the Notch receptor protein determines whether a single progenitor cell produces excitatory or inhibitory neurons. The researchers found that activated Notch promotes excitatory neuron formation, while low levels of Notch lead to inhibitory neuron development.
Researchers discovered a mechanism by which misfolded SOD1 proteins form aggregates that kill motor neurons in ALS. The normal form of SOD1 is recruited to participate in disease formation through intermolecular disulfide bonds, providing potential sites for therapeutic intervention.
Researchers at the Salk Institute identified V1 neurons as crucial for controlling rhythmic movements in the spinal cord, which enables walking. Disabling these neurons slows down the movement, highlighting their importance in locomotion.
Dr. Joseph Culotti's research into nerve cell growth and migration may lead to future spinal cord repair processes. He was awarded the $50,000 Barbara Turnbull Prize in recognition of his contributions to world-leading spinal cord research in Canada.
Treena Arinzeh, a NJIT engineer, has received two new grants to develop stem cell therapies for spinal cord and cartilage injuries. Her research aims to regenerate nerve tissue and promote bone growth using nano-scaffolds.
A study published in Neurology found that over 70% of people with Chiari Malformations experience sleep apnea and daytime sleepiness. Surgery to relieve compression on the brain stem improved symptoms, reducing central sleep apnea occurrences by 90% and micro-arousals by 30%.
Microglia have been found to play a crucial role in neuropathic pain by releasing Brain-Derived Neurotropic Factor (BDNF). BDNF disrupts inhibition in the spinal cord, leading to abnormal pain signals. The discovery offers new hope for diagnostics and treatment of chronic pain.
A new study found that Fezl is necessary for proper development of neural connections to the spinal cord. In developing mice lacking the Fezl gene, normal connections failed to form, and brain cells made inappropriate connections instead.
A pilot study published in BMC Neurology identified 16 proteins in the cerebrospinal fluid of CFS patients that are not found in healthy individuals, potentially providing a biosignature for diagnosis. The study concludes that chronic fatigue syndrome may be a legitimate neurological disease.
Researchers mapped Hox protein expression patterns to understand motor neuron wiring and diversification. The code governs columnar, divisional, and pool identities, enabling precise connections between neurons and muscles.
Johns Hopkins researchers identify elevated levels of IL-6 in spinal fluid of patients with transverse myelitis, a condition that can lead to permanent paralysis. The study also found correlations between IL-6 levels and disease severity, shedding light on the mechanisms behind demyelinating disorders.
Researchers at Johns Hopkins found elevated IL-6 levels correlate with tissue injury and clinical disability in Transverse Myelitis (TM) patients. Elevated IL-6 levels are necessary and sufficient to mediate neural injury, dependent on nitric oxide.
The study identifies aquaporin-4 as the target molecule of the NMO antibody, a significant finding that deviates from previous research on multiple sclerosis. The discovery may lead to the development of new therapies for neuromyelitis optica and other autoimmune disorders.
A team of researchers at the University of Chicago has identified a gradient of biochemical signals, including Wnt proteins and Ryk receptor, that guide nerve growth down the spinal cord. This discovery offers new insights into how to repair or replace damaged nerves in adults.
Researchers found that a combination of precursor cells and gene therapy led to significant improvements in functional recovery from spinal cord injury. The treatment promoted myelination, resulting in improved mobility and electrical activity in the affected area.
Researchers find high levels of acrolein, a known carcinogen, persist in spinal tissue after injury, contributing to debilitating paralysis. Detoxifying drugs targeting acrolein could treat not only spinal cord damage but also other conditions like Parkinson's and Alzheimer's.
A new project provides a comprehensive map of the rat spinal cord, allowing for seamless navigation between rat and human cords to test hypotheses and relate data. The study will also create a 3D stereotaxic space for experimental and clinical observations.